M. A. Hamon and J. Quintin, Innate immune memory in mammals, Semin Immunol, 2016.
URL : https://hal.archives-ouvertes.fr/pasteur-01422825

B. Milutinovic and J. Kurtz, Immune memory in invertebrates, Semin Immunol, vol.28, pp.328-370, 2016.

M. G. Netea, J. Quintin, and J. W. Van-der-meer, Trained immunity: a memory for innate host defense, Cell Host Microbe, vol.9, pp.355-61, 2011.

J. Quintin, S. Saeed, J. H. Martens, E. J. Giamarellos-bourboulis, D. C. Ifrim et al., Netea, Candida albicans infection affords protection against reinfection via functional reprogramming of monocytes, Cell Host Microbe, vol.12, pp.223-255, 2012.

S. Bekkering, B. A. Blok, L. A. Joosten, N. P. Riksen, R. Van-crevel et al., In Vitro Experimental Model of Trained Innate Immunity in Human Primary Monocytes. Clinical and vaccine immunology, CVI, vol.23, pp.926-933, 2016.

M. A. Hoeksema and M. P. De-winther, Epigenetic Regulation of Monocyte and Macrophage Function, Antioxid Redox Signal, vol.25, pp.758-774, 2016.

H. Wen, Y. Dou, C. M. Hogaboam, and S. L. Kunkel, Epigenetic regulation of dendritic cellderived interleukin-12 facilitates immunosuppression after a severe innate immune response, Blood, vol.111, pp.1797-804, 2008.

K. Yoshida, T. Maekawa, Y. Zhu, C. Renard-guillet, B. Chatton et al., The transcription factor ATF7 mediates lipopolysaccharide-induced epigenetic changes in macrophages involved in innate immunological memory, Nat Immunol, vol.16, pp.1034-1077, 2015.

B. Novakovic, E. Habibi, S. Y. Wang, R. J. Arts, R. Davar et al., beta-Glucan Reverses the Epigenetic State of LPS-Induced Immunological Tolerance, Cell, vol.167, pp.1354-1368, 2016.

S. Saeed, J. Quintin, H. H. Kerstens, N. A. Rao, A. Aghajanirefah et al., Epigenetic programming of monocyte-to-macrophage differentiation and trained innate immunity, Science, vol.345, p.1251086, 2014.

S. C. Cheng, J. Quintin, R. A. Cramer, K. M. Shepardson, S. Saeed et al., mTOR-and HIF-1alpha-mediated aerobic glycolysis as metabolic basis for trained immunity, Science, vol.345, p.1250684, 2014.

R. J. Arts, B. Novakovic, R. Horst, A. Carvalho, S. Bekkering et al., Glutaminolysis and Fumarate Accumulation Integrate Immunometabolic and Epigenetic Programs in Trained Immunity, Cell Metab, vol.24, pp.807-819, 2016.

S. Bekkering, R. J. Arts, B. Novakovic, I. Kourtzelis, C. Van-der-heijden et al., Metabolic Induction of Trained Immunity through the Mevalonate Pathway, Cell, vol.172, pp.135-146, 2018.

I. Mitroulis, K. Ruppova, B. Wang, L. S. Chen, M. Grzybek et al., Modulation of Myelopoiesis Progenitors Is an Integral Component of Trained Immunity, Cell, vol.172, pp.147-161, 2018.

R. Chang, Bioactive polysaccharides from traditional Chinese medicine herbs as anticancer adjuvants, J Altern Complement Med, vol.8, pp.559-65, 2002.

O. Rop, J. Mlcek, and T. Jurikova, Beta-glucans in higher fungi and their health effects, Nutr Rev, vol.67, pp.624-655, 2009.

R. P. Pelley and F. M. Strickland, Plants, polysaccharides, and the treatment and prevention of neoplasia, Crit Rev Oncog, vol.11, pp.189-225, 2000.

S. K. Biswas and E. Lopez-collazo, Endotoxin tolerance: new mechanisms, molecules and clinical significance, Trends Immunol, vol.30, pp.475-87, 2009.

D. C. Angus, W. T. Linde-zwirble, J. Lidicker, G. Clermont, J. Carcillo et al., Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care, Crit Care Med, vol.29, pp.1303-1313, 2001.

D. Annane, E. Bellissant, and J. M. Cavaillon, Septic shock, Lancet, vol.365, pp.63-78, 2005.
URL : https://hal.archives-ouvertes.fr/hal-02159416

D. L. Williams, W. Browder, R. Mcnamee, and N. R. Di-luzio, Adv Exp Med Biol, vol.155, pp.701-707, 1982.

E. T. , O. Busayo, and O. J. , The protective effect of beta glucan against Escherichia coli infected mice via intraperitonial administration, Journal of Bacteriology Research, vol.3, issue.2, pp.28-31, 2011.

D. L. Williams, I. W. Browder, and N. R. Di-luzio, Immunotherapeutic modification of Escherichia coli--induced experimental peritonitis and bacteremia by glucan, Surgery, vol.93, pp.448-54, 1983.

D. L. Williams, E. R. Sherwood, I. W. Browder, R. B. Mcnamee, E. L. Jones et al., Effect of glucan on neutrophil dynamics and immune function in Escherichia coli peritonitis, J Surg Res, vol.44, pp.54-61, 1988.

D. L. Williams, T. Ha, C. Li, J. H. Kalbfleisch, J. J. Laffan et al., Inhibiting early activation of tissue nuclear factor-kappa B and nuclear factor interleukin 6 with (1-->3)-beta-D-glucan increases long-term survival in polymicrobial sepsis, Surgery, vol.126, pp.54-65, 1999.

D. L. Williams, T. Ha, C. Li, J. Laffan, J. Kalbfleisch et al., Inhibition of LPSinduced NFkappaB activation by a glucan ligand involves down-regulation of IKKbeta kinase activity and altered phosphorylation and degradation of IkappaBalpha, Shock, vol.13, pp.446-52, 2000.

D. L. Williams, C. Li, T. Ha, T. Ozment-skelton, J. H. Kalbfleisch et al., Modulation of the phosphoinositide 3-kinase pathway alters innate resistance to polymicrobial sepsis, J Immunol, vol.172, pp.449-56, 2004.

N. R. Di-luzio and D. L. Williams, Protective effect of glucan against systemic Staphylococcus aureus septicemia in normal and leukemic mice, Infect Immun, vol.20, pp.804-814, 1978.

I. W. Browder, D. L. Williams, A. Kitahama, and N. R. Di-luzio, Modification of postoperative C. albicans sepsis by glucan immunostimulation, Int J Immunopharmacol, vol.6, pp.19-26, 1984.

A. O. Tzianabos, F. C. Gibson, R. L. Cisneros, and D. L. Kasper, Protection against experimental intraabdominal sepsis by two polysaccharide immunomodulators, J Infect Dis, vol.178, pp.200-206, 1998.

A. Sandvik, Y. Y. Wang, H. C. Morton, A. O. Aasen, J. E. Wang et al., Oral and systemic administration of beta-glucan protects against lipopolysaccharide-induced shock and organ injury in rats, Clin Exp Immunol, vol.148, pp.168-77, 2007.

G. Sener, H. Toklu, F. Ercan, and G. Erkanli, Protective effect of beta-glucan against oxidative organ injury in a rat model of sepsis, Int Immunopharmacol, vol.5, pp.1387-96, 2005.

L. Rizzetto, D. C. Ifrim, S. Moretti, N. Tocci, S. C. Cheng et al., Fungal chitin induces trained immunity in human monocytes during cross-talk of the host with Saccharomyces cerevisiae, J Biol Chem, 2016.

K. Suzuki, Y. Okawa, K. Hashimoto, S. Suzuki, and M. Suzuki, Protecting effect of chitin and chitosan on experimentally induced murine candidiasis, Microbiol Immunol, vol.28, pp.903-915, 1984.

Y. Okawa, K. Suzuki, M. Kobayashi, M. Asagi, K. Sakai et al., Protective effect of acidic mannan fraction of bakers' yeast on experimental candidiasis in mice, Microbiol Immunol, vol.30, pp.957-67, 1986.

N. R. Di-luzio and D. L. Williams, Glucan-induced modification of the increased susceptibility of cyclophosphamide-treated mice to Staphylococcus aureus infection, Cancer Immunol Immunother, vol.6, 1979.

B. M. Buddle, H. D. Pulford, and M. Ralston, Protective effect of glucan against experimentally induced staphylococcal mastitis in ewes, Vet Microbiol, vol.16, pp.67-76, 1988.

G. Hetland, M. Lovik, and H. G. Wiker, Protective effect of beta-glucan against mycobacterium bovis, BCG infection in BALB/c mice, Scand J Immunol, vol.47, pp.548-53, 1998.

J. A. Cook, T. W. Holbrook, and W. J. Dougherty, Protective effect of glucan against visceral leishmaniasis in hamsters, Infect Immun, vol.37, pp.1261-1270, 1982.

A. S. Tuwaijri, A. A. Mahmoud, I. A. Mofleh, and S. A. Khuwaitir, Effect of glucan on Leishmania major infection in BALB/c mice, J Med Microbiol, vol.23, pp.363-368, 1987.

D. L. Williams and N. R. Di-luzio, Glucan-induced modification of murine viral hepatitis, Science, vol.208, pp.67-76, 1980.

K. Jung, Y. Ha, S. K. Ha, D. U. Han, D. W. Kim et al., Antiviral effect of Saccharomyces cerevisiae beta-glucan to swine influenza virus by increased production of interferon-gamma and nitric oxide, Journal of veterinary medicine, vol.51, pp.72-78, 2004.

J. A. Reynolds, M. D. Kastello, D. G. Harrington, C. L. Crabbs, C. J. Peters et al., Glucan-induced enhancement of host resistance to selected infectious diseases, Infect Immun, vol.30, pp.51-58, 1980.

I. Lavi, D. Levinson, I. Peri, L. Nimri, Y. Hadar et al., Orally administered glucans from the edible mushroom Pleurotus pulmonarius reduce acute inflammation in dextran sulfate sodium-induced experimental colitis, Br J Nutr, vol.103, pp.393-402, 2010.

F. Han, H. Fan, M. Yao, S. Yang, and J. Han, Oral administration of yeast ? -glucan ameliorates inflammation and intestinal barrier in dextran sodium sulfate-induced acute colitis, Journal of Functional Foods, vol.35, pp.115-126, 2017.

S. E. Heinsbroek, D. L. Williams, O. Welting, S. L. Meijer, S. Gordon et al., Orally delivered beta-glucans aggravate dextran sulfate sodium (DSS)-induced intestinal inflammation, Nutr Res, vol.35, pp.1106-1118, 2015.

P. J. Rice, B. E. Lockhart, L. A. Barker, E. L. Adams, H. E. Ensley et al., -3)-beta-D-glucans following intravenous administration in rats, Pharmacokinetics of fungal, vol.4, pp.1209-1224, 2004.

H. Yoshitomi, N. Sakaguchi, K. Kobayashi, G. D. Brown, T. Tagami et al.,

. Sakaguchi, A role for fungal {beta}-glucans and their receptor Dectin-1 in the induction of autoimmune arthritis in genetically susceptible mice, J Exp Med, vol.201, pp.949-60, 2005.

M. Ruutu, G. Thomas, R. Steck, M. A. Degli-esposti, M. S. Zinkernagel et al., beta-glucan triggers spondylarthritis and Crohn's disease-like ileitis in SKG mice, Arthritis Rheum, vol.64, pp.2211-2233, 2012.

S. Bekkering, J. Quintin, L. A. Joosten, J. W. Van-der-meer, M. G. Netea et al., Oxidized low-density lipoprotein induces long-term proinflammatory cytokine production and foam cell formation via epigenetic reprogramming of monocytes, Arterioscler Thromb Vasc Biol, vol.34, pp.1731-1739, 2014.

J. Chen and K. Raymond, Beta-glucans in the treatment of diabetes and associated cardiovascular risks. Vasc Health Risk Manag, vol.4, pp.1265-72, 2008.

G. C. Chan, W. K. Chan, and D. M. Sze, The effects of beta-glucan on human immune and cancer cells, J Hematol Oncol, vol.2, p.25, 2009.

A. T. Borchers, J. S. Stern, R. M. Hackman, C. L. Keen, and M. E. Gershwin, Mushrooms, tumors, and immunity, Proc Soc Exp Biol Med, vol.221, pp.281-93, 1999.

M. Zhang, J. A. Kim, and A. Y. Huang, Optimizing Tumor Microenvironment for Cancer Immunotherapy: beta-Glucan-Based Nanoparticles, Frontiers in immunology, vol.9, p.341, 2018.

G. D. Ross, V. Vetvicka, J. Yan, Y. Xia, and J. Vetvickova, Therapeutic intervention with complement and beta-glucan in cancer, Immunopharmacology, vol.42, pp.61-74, 1999.

V. Vetvicka, B. P. Thornton, and G. D. Ross, Soluble beta-glucan polysaccharide binding to the lectin site of neutrophil or natural killer cell complement receptor type 3 (CD11b/CD18) generates a primed state of the receptor capable of mediating cytotoxicity of iC3b-opsonized target cells, J Clin Invest, vol.98, pp.50-61, 1996.

V. Vetvicka and J. Vetvickova, Combination of glucan, resveratrol and vitamin C demonstrates strong anti-tumor potential, Anticancer Res, vol.32, pp.81-88, 2012.

F. Hong, R. D. Hansen, J. Yan, D. J. Allendorf, J. T. Baran et al., Beta-glucan functions as an adjuvant for monoclonal antibody immunotherapy by recruiting tumoricidal granulocytes as killer cells, Cancer research, vol.63, pp.9023-9054, 2003.

F. Hong, J. Yan, J. T. Baran, D. J. Allendorf, R. D. Hansen et al., Mechanism by which orally administered beta-1,3-glucans enhance the tumoricidal activity of antitumor monoclonal antibodies in murine tumor models, J Immunol, vol.173, pp.797-806, 2004.

T. J. Yoon, T. J. Kim, H. Lee, K. S. Shin, Y. P. Yun et al., Anti-tumor metastatic activity of beta-glucan purified from mutated Saccharomyces cerevisiae, Int Immunopharmacol, vol.8, pp.36-42, 2008.

N. Sakaguchi, T. Takahashi, H. Hata, T. Nomura, T. Tagami et al., Altered thymic T-cell selection due to a mutation of the ZAP-70 gene causes autoimmune arthritis in mice, Nature, vol.426, pp.454-60, 2003.

A. Bedirli, M. Kerem, H. Pasaoglu, N. Akyurek, T. Tezcaner et al., Beta-glucan attenuates inflammatory cytokine release and prevents acute lung injury in an experimental model of sepsis, Shock, vol.27, pp.397-401, 2007.

C. T. Newsome, B. Leblanc, A. Ayala, and J. Reichner, The effects of beta-glucan treatment on endotoxin and sepsis-induced cytokine production, FASEB J, vol.23, 2009.

C. T. Newsome, E. Flores, A. Ayala, S. Gregory, and J. S. Reichner, Improved antimicrobial host defense in mice following poly-(1,6)-beta-D-glucopyranosyl-(1,3)-beta-Dglucopyranose glucan treatment by a gender-dependent immune mechanism, Clinical and vaccine immunology : CVI, vol.18, pp.2043-2052, 2011.

Z. Mirza, E. R. Soto, F. Dikengil, S. M. Levitz, and G. R. Ostroff, Beta-Glucan Particles as Vaccine Adjuvant Carriers, Methods Mol Biol, vol.1625, pp.143-157, 2017.

N. N. Acar, Ü. Noyan, L. Kuru, T. Kadir, and B. Kuru, Adjunctive Systemic Use of ?eta-Glucan in the Nonsurgical Treatment of Chronic Periodontitis, 2012.